Xarelto on Prevention of Stroke and Non-Central Nervous Systemic Embolism in Renally Impaired Korean Patients With Non-valvular Atrial Fibrillation

Clinical trial NCT03746301 · COMPLETED

Trial details

NCT number: NCT03746301
Sponsor: Bayer
Status: COMPLETED
Study type: OBSERVATIONAL

Non-valvular Atrial Fibrillation (NVAF)

Start date: 2018-12-03
Primary completion: 2021-07-28
Enrollment: 924

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.